drugset / Trial / NCT01432522

A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine

NCT01432522

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is a preliminary report of pharmacokinetic data of epinephrine administered via intranasal route (IN) comparing with intramuscular (IM) route in healthy adult volunteers.

Timeline

Start
2010-07
Primary completion
2011-08
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified 0.3 mg Intranasal
Subject Epinephrine Other / unclassified 5 mg Intranasal

Indications